OptiBiotix Health Plc (LON:OPTI – Get Free Report) shares fell 16.4% on Wednesday . The company traded as low as GBX 11.50 ($0.15) and last traded at GBX 11.50 ($0.15). 440,200 shares changed hands during trading, an increase of 42% from the average session volume of 310,102 shares. The stock had previously closed at GBX 13.75 ($0.18).
OptiBiotix Health Price Performance
The company has a debt-to-equity ratio of 4.51, a quick ratio of 7.89 and a current ratio of 7.67. The company has a 50-day moving average of GBX 20.75 and a 200-day moving average of GBX 19.60. The stock has a market capitalization of £12.17 million, a price-to-earnings ratio of -458.33 and a beta of 1.71.
OptiBiotix Health Company Profile
OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits.
Further Reading
- Five stocks we like better than OptiBiotix Health
- 3 Fintech Stocks With Good 2021 Prospects
- NVIDIA’s AI Dominance: Why Analysts Predict Major Upside Ahead
- Using the MarketBeat Dividend Tax Calculator
- These Stocks Are Using Buybacks to Unlock Big Gains for Investors
- Stock Dividend Cuts Happen Are You Ready?
- This Is the Entry Into PepsiCo You’ve Been Waiting For
Receive News & Ratings for OptiBiotix Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health and related companies with MarketBeat.com's FREE daily email newsletter.
